A randomized trial of short-term treatment of Graves' disease with high- dose carbimazole plus thyroxine versus low-dose carbimazole

Clinical Endocrinology

Volumn 48, Issue 5, 1998, Pages 585-592

  Grebe, Stefan K G ^a   Feek, Colin M ^b,c   Ford, Henry C ^a   Fagerström, Jocelyn N ^b   Cordwell, Diane P ^b   Delahunt, John W ^a,b   Toomath, Robyn J ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b WELLINGTON HOSPITAL   (New Zealand)

^c MINISTRY OF HEALTH   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CARBIMAZOLE; THYROXINE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; DRUG TOLERABILITY; FEMALE; GRAVES DISEASE; HUMAN; MALE; PRIORITY JOURNAL; RELAPSE; SURVIVAL; THYROID FUNCTION TEST;

ADULT; ANTITHYROID AGENTS; CARBIMAZOLE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; GRAVES DISEASE; HUMANS; MALE; PROSPECTIVE STUDIES; RECURRENCE; THYROID FUNCTION TESTS; THYROXINE; TIME FACTORS;

EID: 0031777412     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1998.00446.x     Document Type: Article

References (27)

1. Abacus Concepts (1989) SuperANOVA. Abacus Concepts. Inc., Berkley, CA, USA.
2. Abacus Concepts (1994) StatView 4.5. Abacas Concepts, Inc., Berkley, CA, USA.
3. Cooper. D.S. (1996) Treatment of thyrotoxicosis. In Werner and Ingbar's The Thyroid (eds L. E. Braverman & R. D. Utiger), pp. 713-734. Lippincott-Raven, Philadelphía.
4. Davies, T.F., Yang, C. & Platzer, M. (1989) The influence of antithyroid drugs and iodine on thyroid cell MHC class II antigen expression. Clinical Endocrinology, 31, 125-135.
5. Duprey. J., Louis, M.F., Ducomet, B., Lifchitz, E., Mosse, A. & Sultan, M. (1988) Amelioration du pronostic de la maladie de Basedow par utilisation de fortes doses de carbimazole. Presse Medicale, 17, 1124-1127.
6. Edmonds, C.J. & Tellez, M. (1994) Treatment of Graves' disease by carbimazole: high dose with thyroxine compared to titration dose. European Journal of Endocrinology, 131, 120-124.
7. Escobar-Morreale, H.F., Serrano-Gotarredona, J., Villar, L.M., GarciaRobles, R., Gonzalez-Porque, P., Sancho, J.M. & Varela, C. (1996) Methimazole has no dose-related effect on the serum concentrations of soluble class I major histocompatibility complex antigens, soluble interleukin-2 receptor, and beta 2-microglobulin in patients with Graves' disease. Thyroid, 6, 29-36.
8. Ford, H.C. & Carter, J.M. (1988) The haematology of hyperthyroidism: abnormalities of erythrocytes, leucocytes, thrombocytes and haemostasis. Postgraduate Medical Journal, 64, 735-742.
9. Ford, H.C., Delahunt, J.W. & Feek, C.M. (1991) The management of Graves' disease in New Zealand: results of a national survey. New Zealand Medical Journal, 101, 251-252.
10. Franklyn, J.A. (1994) The management of hyperthyroidism. New England Journal of Medicine, 330, 1731-1738.
11. Greer, M.A., Kammer, H. & Bouma, D.J. (1977) Short-term antithyroid drug therapy tor the thyrotoxicosis of Graves' disease. New England Journal of Medicine, 297, 173-176.
12. Hashizume, K., Ichikawa, K., Sakurai, A., Suzukui, S., Takeda, T., Kobayashi, M., Miyamoto, T., Arai, M. & Nagasawa, T. (1991) Administration of thyroxine in treated Graves' disease. New England Journal of Medicine, 324, 947-953.
13. International Agranulocytosis and Aplastic Anaemia Study (1988) Risk of agranulocytosis and aplastic anaemia in relation to use of antithyroid drugs. British Medical Journal, 297, 262-265.
14. Jorde, R., Ytre-Arne, K., Stormer, J. & Sundsfjord, J. (1995) Short-term treatment of Graves' disease with methimazole in high versus low doses. Journal of Internal Medicine, 238, 161-165.
15. Kampmann, J.P. & Hansen, J.M. (1981) Clinical pharmacokinetics of antithyroid drugs. Clinical Pharmacokinetics, 6, 401-428.
16. Lucas, A., Salinas, I., Rius, F., Pizarro, E., Granada, M.L., Foz, M. & Sanmarti, A. (1997) Medieal therapy of Graves'-disease - does thyroxine prevent recurrence of hyperthyroidism? Journal of Clinical Endocrinology and Metabolism, 82, 2410-2413.
17. MacFarlane, I.A., Davies, D., Longson, D., Shalet, S.M. & Beardwell, C.G. (1983) Single daily dose short term carbimazole therapy for hyperthyroid Graves' disease. Clinical Endocrinology. 18, 557-561.
18. Mclver, B., Rae, P., Beckett, G., Wilkinson, E., Gold, A. & Toft, A. (1996) Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug. New England Journal of Medicine, 334, 220-224.
19. Paschke, R., Vogg, M., Kristoferitsch, R., Aktuna, D., Wawschinek, O., Eher, O. & Usadel, K.H. (1995) Methimazole has no dose-related effect on the intensity of the intrathyroidal autoimmune process in relapsing Graves' disease. Journal of Clinical Endocrinology and Metabolism, 80, 2470-2474.
20. Reinwein, D., Benker, G., Lazarus, J.H. & Alexander, W.D. (1993) A prospective randomized trial of antithyroid drug dose in Graves' disease therapy. European Multicenter Study Group on Antithyroid Drug Treatment. Journal of Clinical Endocrinology and Metabolism, 76, 1516-1521.
21. Reis, L.C.F., Romaldini, J.H. & Bromberg, N. (1977) High remissionrate in hyperthyroidism: correlation with 'total thyroidal rest therapy'. Revista Brasileira de Pesquisas Medicas e Biologicas, 10, 311-318.
22. Rittmaster, R.S., Abbott, E.C., Douglas, R., Givner, M.L., Lomas, H., Lehmann, L., Reddy, S., Salisbury, S.R., Shlossberg, A.H., Tan, M.H. & York, S.E. (1997) Effect of methimazole plus thyroxine on relapse rates in Graves' disease (GD). Proceedings of the American Endocrine Society's 79th Annual Scientific Meeting, OR19-5, 92 (Abstract).
23. Romaldini, J.H., Bromberg, N., Werner, R.S., Tanaka, L.M., Rodrigues, H.F., Werner, M.C., Farah, C.S. & Reis, L.C. (1983) Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism. Journal of Clinical Endocrinology and Metabolism, 57, 563-570.
24. Volpe, R. (1994) Evidence that the immunosuppressive effects of antithyroid drugs are mediated through actions on the thyroid cell, modulating thyrocyte-immunocyte signaling: a review. Thyroid, 4, 217-223.
25. Wartofsky, L., Glinoer, D., Solomon, B., Nagataki, S., Lagasse, R., Izumi, M., Nagayama, Y. & Izumi, M. (1991) Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States. Thyroid, 1, 129-135.
26. Weetman, A.P., McGregor, A.M. & Hall, R. (1984) Evidence for an effect of antithyroid drugs on the natural history of Graves' disease. Clinical Endocrinology, 21, 163-172.
27. Weetman, A.P., Tandon, N. & Morgan, B.P. (1992) Antithyroid drugs and release of inflammatory mediators by complement-attacked thyroid cells. Lancet, 340, 633-636.